Homehealth sector stocks

health sector stocks

What’s in Store for These 3 Big Pharma Outperformers in 2022?

What’s in Store for These 3 Big Pharma Outperformers in 2022?

March 9, 2022

AbbVie Resolves HUMIRA® (adalimumab) U.S. Litigation with Alvotech

AbbVie Resolves HUMIRA® (adalimumab) U.S. Litigation with Alvotech

March 8, 2022

AMGEN TO PRESENT LONG-TERM OUTCOMES FOR LUMAKRAS® (SOTORASIB) IN KRAS G12C-MUTATED NSCLC AT AACR 2022

AMGEN TO PRESENT LONG-TERM OUTCOMES FOR LUMAKRAS® (SOTORASIB) IN KRAS G12C-MUTATED NSCLC AT AACR 2022

March 8, 2022

Gilead’s (GILD) Trodelvy Late-Line Breast Cancer Study Meets Goal

Gilead’s (GILD) Trodelvy Late-Line Breast Cancer Study Meets Goal

March 8, 2022

Horizon’s (HZNP) sBLA for Krystexxa Gets FDA Priority Review

Horizon’s (HZNP) sBLA for Krystexxa Gets FDA Priority Review

March 8, 2022

AbbVie (ABBV) Outperforms Industry This Year So Far: What Next?

AbbVie (ABBV) Outperforms Industry This Year So Far: What Next?

March 8, 2022

AbbVie (ABBV) Stock Moves -0.74%: What You Should Know

AbbVie (ABBV) Stock Moves -0.74%: What You Should Know

March 7, 2022

Bristol Myers Squibb (BMY) Stock Moves -0.85%: What You Should Know

Bristol Myers Squibb (BMY) Stock Moves -0.85%: What You Should Know

March 7, 2022

FDA Nods to Bristol Myers’ (BMY) Opdivo for Additional Indication

FDA Nods to Bristol Myers’ (BMY) Opdivo for Additional Indication

March 7, 2022

GLOBAL BIOTECHNOLOGY LEADER AMGEN BREAKS GROUND ON NEW MANUFACTURING FACILITY IN NORTH CAROLINA

GLOBAL BIOTECHNOLOGY LEADER AMGEN BREAKS GROUND ON NEW MANUFACTURING FACILITY IN NORTH CAROLINA

March 7, 2022

« 1 … 85 86 87 88 89 … 449 »